ONCOLife Issues
Featured Articles
Trending Articles
FDA Grants Breakthrough Status to WU-CART-007 for T-Cell Leukemias and Lymphomas
FDA & EMA | 1 April 2026
AI Predicts Who Benefits from Chemotherapy in Breast Cancer Using Routine Pathology Slides
Clinical Trials | 30 March 2026
FDA Approves Agilent’s PD-L1 Test to Guide KEYTRUDA Use in Esophageal and GEJ Carcinoma
FDA & EMA | 28 March 2026
Light-Activated Copper Nanoparticles Trigger Cuproptosis in Drug-Resistant Cancer Cells
ONCOLife | 27 March 2026
New Protein Modification Linked to IDH-Mutant Cancers Opens Therapeutic Possibilities
ONCOLife | 26 March 2026
BioNTech Showcases Promising Bispecific and ADC Data in Lung Cancer at ELCC 2026
ONCOLife | 25 March 2026
Sunvozertinib Outperforms Chemo in First-Line EGFR Exon 20 Insertion NSC Lung Cancer
ONCOLife | 22 March 2026
Magnetic Nanoparticle-Guided Hyperthermia Opens a New Path for Advanced Solid Tumors
ONCOLife | 23 March 2026
TG Therapeutics Secures $500M to Advance BRIUMVI in Relapsing Multiple Sclerosis
Biotech | 20 March 2026
Targeted Bladder Cancer Therapy Erda-iDRS Achieves 89% Response Rate and PDC
ONCOLife | 15 March 2026
Atirmociclib Reduces Progression Risk by 40% in CDK4/6 Metastatic Breast Cancer
ONCOLife | 17 March 2026
TALAPRO-3 Trial Supports Early Use of Talazoparib in HRR+ mCS Prostate Cancer
ONCOLife | 20 March 2026
Vitamin B2’s Hidden Role in Cancer Survival May Open a New Therapeutic Target
ONCOLife
14 March 2026
Romiplostim Prevents Chemotherapy Side Effects and Preserves Treatment Intensity
ONCOLife
14 March 2026
PSMA PET/CT May Transform Prostate Cancer Diagnosis and Reduce Biopsies by 50%
ONCOLife
13 March 2026
Designing Digital Healthcare Systems for the Future of Patient-Centered Care
Digital Health
4 March 2026
Amivantamab Plus Chemotherapy Shows Promising Responses in Colorectal Cancer
Clinical Trials
11 January 2026
Novartis Expands US Radioligand Manufacturing With $23 Billion Investment in Florida
Pharma
9 January 2026
TRBC2-Specific ADC Shows Robust Efficacy in T-Cell Lymphomas and Leukemias
Clinical Trials
24 December 2025
Engineered Oncolytic Virus Reprograms Immunity and Extends Survival in Brain Cancer
ONCOLife
20 December 2025
FDA Approves First Subcutaneous Amivantamab Plus Lazertinib for EGFR+ Lung Cancer
FDA & EMA
18 December 2025
Platinum-Free PADCEV Plus Pembrolizumab Improves Survival in MI Bladder Cancer
Clinical Trials
18 December 2025